Navigation Links
Quintessence Biosciences forms cancer therapeutic advisory board


MADISON Quintessence Biosciences, Inc. has formed a scientific advisory board to guide the company in its development of cancer therapeutics.

Announced last week by President and Chief Executive Officer Ralph Kauten, the board will consist of distinguished s......

Full article >>> ed in 2003, Quintessence Biosciences, Inc. is a company engaged in creating products based on chemistry and biochemistry technologies discovered at UW-Madison and licensed from the Wisconsin Alumni Research Foundation.......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 06/21/04


Related biology technology :

1. Quintessence Biosciences advances cancer drug
2. Quintessence Biosciences names new president
3. Quintessence cancer treatment chosen for clinical studies
4. Quintessence division to develop drug tests with NIH grant
5. Quintessence Secures Financing
6. Perscitus Biosciences secures $250K Commerce loan
7. Caden Biosciences may signal critical mass
8. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
9. WARF signs licensing pact with BD Biosciences
10. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
11. State awards QRG Biosciences development grant
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/2/2019)... ... February 01, 2019 , ... Biomatlante, a world leader in ... CEO, Julien Dert, being effective on February 1st, 2019. , Graduated from ICN ... in which more than 12 years in the Medical Device industry. Chief Financial ...
(Date:1/30/2019)... ... January 29, 2019 , ... Actus Therapeutics, a ... of the first patient in a phase 1/2 clinical study of ACTUS-101 in ... high morbidity and often leads to premature death. There are variable rates ...
(Date:1/30/2019)... ... 2019 , ... Through its Microbiome Grant Initiative , ... design, planning, sample collection, and analysis to a team of researchers at North ... the interactions between gut microbial composition and cardiovascular health risks, such as hypertension ...
(Date:1/24/2019)... ... January 22, 2019 , ... Dr. Douglas Stramel of Advanced Care Veterinary ... Therapy System (V-PET™) for nearly three years. A proponent of Regenerative Medicine, ... 2007 and began using V-PET™ 2016. V-PET™ is a gravity filtration-based platelet therapy ...
Breaking Biology Technology:
(Date:2/19/2019)... (PRWEB) , ... February 19, 2019 , ... ... the appointment of Mark Hozza as Chief Commercial Officer of the life science ... responsible for the performance, strategy, and alignment of all market research and media ...
(Date:2/14/2019)... ... February 14, 2019 , ... This year’s ... will host 80 scientific sessions and 2,100 presentations. Given SOT’s mission to bring ... its OpenLiver™ 3D cell culture model initiative that it recently launched ...
(Date:2/13/2019)... ... February 13, 2019 , ... ... of medical marijuana legally through patient clinical trials and research, announced that it ... grants Fast Track Designation to help expedite the review and approval of drugs ...
Breaking Biology News(10 mins):